Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-o-demethylsirolimus
2. 16-o-demethylrapamycin
3. Rapamycin, 7-o-demethyl-
4. Cj-12263
5. 7-o-demethyl Rapamycin
6. 2719uahua8
7. 7-o-demethyl Cypher
8. 7-o-demethylrapamycin
9. 16-o-demethylsirolimus
10. N-929-89b
11. 151519-50-5
12. 7-o-demethyl Rapammune
13. Novolimus (80%)
14. Unii-2719uahua8
15. Schembl7715643
16. Chembl3544688
17. 7-o-demethyl Rapamycin (~80%)
18. Cj12263
19. Cj 12263
20. Hy-123691
21. Cs-0084352
| Molecular Weight | 900.1 g/mol |
|---|---|
| Molecular Formula | C50H77NO13 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 5 |
| Exact Mass | 899.53949151 g/mol |
| Monoisotopic Mass | 899.53949151 g/mol |
| Topological Polar Surface Area | 206 Ų |
| Heavy Atom Count | 64 |
| Formal Charge | 0 |
| Complexity | 1740 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
32
PharmaCompass offers a list of Novolimus API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Novolimus manufacturer or Novolimus supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Novolimus manufacturer or Novolimus supplier.
PharmaCompass also assists you with knowing the Novolimus API Price utilized in the formulation of products. Novolimus API Price is not always fixed or binding as the Novolimus Price is obtained through a variety of data sources. The Novolimus Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 16-O-Demethylsirolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 16-O-Demethylsirolimus, including repackagers and relabelers. The FDA regulates 16-O-Demethylsirolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 16-O-Demethylsirolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 16-O-Demethylsirolimus supplier is an individual or a company that provides 16-O-Demethylsirolimus active pharmaceutical ingredient (API) or 16-O-Demethylsirolimus finished formulations upon request. The 16-O-Demethylsirolimus suppliers may include 16-O-Demethylsirolimus API manufacturers, exporters, distributors and traders.
16-O-Demethylsirolimus Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 16-O-Demethylsirolimus GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 16-O-Demethylsirolimus GMP manufacturer or 16-O-Demethylsirolimus GMP API supplier for your needs.
A 16-O-Demethylsirolimus CoA (Certificate of Analysis) is a formal document that attests to 16-O-Demethylsirolimus's compliance with 16-O-Demethylsirolimus specifications and serves as a tool for batch-level quality control.
16-O-Demethylsirolimus CoA mostly includes findings from lab analyses of a specific batch. For each 16-O-Demethylsirolimus CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
16-O-Demethylsirolimus may be tested according to a variety of international standards, such as European Pharmacopoeia (16-O-Demethylsirolimus EP), 16-O-Demethylsirolimus JP (Japanese Pharmacopeia) and the US Pharmacopoeia (16-O-Demethylsirolimus USP).
